November 11, 2020 07:57 AM EST

Expected mistakes, the need for speed, and change to come: CBER's Peter Marks looks ahead

Kari Oakes

In a wide-ranging Nov. 6 discussion with the president and CEO of the Friends of Cancer Research, Jeff Allen, CBER director Marks spoke to tempering …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Expected mistakes, the need for speed, and change to come: CBER's Peter Marks looks ahead

Kari Oakes

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Summit’s disappointing survival readout raises stakes for full data

Summit says bispecific misses overall survival in closely-watched lung cancer study

Another Bristol Myers exec goes to Acadia; David Southwell takes CEO job at ARCH-backed cancer biotech

HHS says it's pulled Covid shot guidance for healthy kids. The CDC vaccine schedule shows otherwise

Sanofi, Regeneron report underwhelming COPD data for IL-33 antibody, shares drop

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Ex­pect­ed mis­takes, the need for speed, and change to come: CBER's Pe­ter Marks looks ahead

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Expected mistakes, the need for speed, and change to come: CBER's Peter Marks looks ahead